Dr. Damiano Rondelli, MD

Dr. Rondelli practices at University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System.

Dr. Rondelli's NPI, 1528198884, was assigned on March 6, 2007.

Dr. Rondelli's primary practice is University of Illinois Hospital, at 1740 West Taylor St Suite 1400, Chicago, IL 60612 in Cook County. The practice phone is (312) 996-3900.

Dr. Rondelli's primary practice is University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System. The medical group on file is University of Illinois Physicians Group (UIPG).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rondelli practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Rondelli's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Rondelli has a license on file in Illinois.

CMS data shows 114 Medicare services from Dr. Rondelli across 2 procedure codes in 2024, for 47 Medicare patients. Medicare paid $5,910 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 47 Medicare patients who saw Dr. Rondelli in 2024. The largest group is 65 to 74, with 23 patients. 72% of them have high blood pressure, and 60% have high cholesterol. 55% are also on Medicaid. Their average risk score is 4.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rondelli's median patient age at 61, with 56% women.

In 2024, Dr. Rondelli wrote 116 Medicare Part D claims for 20 patients. 48% of them were for generic drugs. CMS names the drug for 35 of them, across 1 drug with 11 or more claims each, at $578,761 in total drug cost. In 2021, CMS named 37 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Rondelli for performance year 2024, reported as part of a group. Dr. Rondelli accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 97 papers to Dr. Rondelli, published from 2005 to 2025. 2019 was the busiest year, with 14. The most frequent topics are Hematopoietic Stem Cell Transplantation, Transplantation Conditioning and Multiple Myeloma. Dr. Rondelli has published most often in Bone Marrow Transplant. Dr. Rondelli's most frequent co-authors are Nadim Mahmud, MD, MPH, MS, Santosh Lumdas Saraf, MD and Annie Lee Oh, MD.

Dmand AI links Dr. Rondelli to 9 clinical trials, 2 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Thrombocythemia, Essential, Thrombocytosis and Anemia, Sickle Cell. Icahn School of Medicine at Mount Sinai sponsors the most, 3.

CMS Open Payments shows 56 general payments to Dr. Rondelli from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 89% of the total. Vertex Pharmaceuticals Incorporated paid the most, $27,807.